ASP Isotopes Inc. (NASDAQ:ASPI) Stake Lifted by AWM Investment Company Inc.

AWM Investment Company Inc. grew its stake in ASP Isotopes Inc. (NASDAQ:ASPI - Free Report) by 16.0% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 4,246,186 shares of the company's stock after purchasing an additional 586,600 shares during the quarter. ASP Isotopes comprises about 2.3% of AWM Investment Company Inc.'s holdings, making the stock its 10th biggest holding. AWM Investment Company Inc. owned about 5.95% of ASP Isotopes worth $19,235,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also added to or reduced their stakes in the company. Hanson & Doremus Investment Management purchased a new position in shares of ASP Isotopes in the fourth quarter worth $27,000. BNP Paribas Financial Markets purchased a new position in shares of ASP Isotopes in the fourth quarter worth approximately $34,000. Avantax Advisory Services Inc. bought a new stake in shares of ASP Isotopes during the 4th quarter valued at $45,000. Russell Investments Group Ltd. raised its holdings in ASP Isotopes by 56.3% in the 4th quarter. Russell Investments Group Ltd. now owns 10,221 shares of the company's stock worth $46,000 after purchasing an additional 3,682 shares during the period. Finally, SVB Wealth LLC purchased a new stake in ASP Isotopes in the fourth quarter worth about $49,000. 16.80% of the stock is currently owned by institutional investors.

ASP Isotopes Trading Up 10.1%

Shares of ASP Isotopes stock traded up $0.79 during trading on Monday, hitting $8.59. The stock had a trading volume of 12,318,486 shares, compared to its average volume of 2,560,220. ASP Isotopes Inc. has a 12 month low of $1.86 and a 12 month high of $9.33. The company has a debt-to-equity ratio of 0.80, a current ratio of 7.55 and a quick ratio of 7.54. The firm's fifty day simple moving average is $5.57 and its 200-day simple moving average is $5.44. The stock has a market cap of $644.78 million, a PE ratio of -14.08 and a beta of 3.40.

Insider Activity at ASP Isotopes

In other news, COO Robert Ainscow sold 66,666 shares of the company's stock in a transaction dated Tuesday, April 15th. The shares were sold at an average price of $5.75, for a total value of $383,329.50. Following the transaction, the chief operating officer now directly owns 1,553,326 shares in the company, valued at approximately $8,931,624.50. This represents a 4.12% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Paul Elliot Mann sold 316,666 shares of ASP Isotopes stock in a transaction that occurred on Thursday, April 17th. The shares were sold at an average price of $5.62, for a total transaction of $1,779,662.92. Following the sale, the chief executive officer now directly owns 7,315,454 shares of the company's stock, valued at $41,112,851.48. This represents a 4.15% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 766,667 shares of company stock worth $4,358,502. Insiders own 21.40% of the company's stock.

Wall Street Analyst Weigh In

Separately, Canaccord Genuity Group increased their price objective on shares of ASP Isotopes from $8.50 to $11.00 and gave the stock a "buy" rating in a research note on Wednesday, May 21st.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.